Ipca Laboratories in process of obtaining environmental clearance for new plant in MP

17 Aug 2020 Evaluate

Ipca Laboratories is in the process of obtaining environmental clearance for setting up a new active pharmaceutical ingredients (API) manufacturing unit at Dewas, Madhya Pradesh (MP) with an initial capital outlay of about Rs 250 crore. The company has already acquired land for the project. Currently, it produces over 80 APIs at 12 production facilities, accounting for nearly 25 percent of its turnover.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×